Inicio | Buscar

Buscar

Resultados de la búsqueda

RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

... Havana, National Institute of Oncology and Radiobiology, Elías A. Gracia Medina, MD, first degree specialist in Oncology Havana, Hospital ...

Clinical Trials - CIM - 19/07/2023 - 3:30pm

Dose scale-up and cohort expansion with the therapeutic mAb 14F7

... Second Degree Specialist in Oncology Affiliation:  National Institute for Oncology and Radiobiology (INOR) Postal ...

Clinical Trials - CIM - 19/07/2023 - 3:22pm

Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)

... First degree specialist in Oncology. Affiliation:  ... Barbara Iglesias Castillo, MD, Second Degree Specialist in Oncology. Research ethics committees:  ...

Clinical Trials - CIM - 19/07/2023 - 3:22pm

NGcGM3/VSSP in small cell lung cancer

... Second degree specialist in Oncology Affiliation:  ... Second degree specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 19/07/2023 - 2:40pm

CENTAURO-4 Study

... 2nd Degree Specialist in Oncology Affiliation:  ... Yamirka Sanchez Azcuy, MD. 2nd Degree Specialist in Oncology. Havana, Center for ...

Clinical Trials - CIGB - 19/07/2023 - 1:08pm

HEBERFERON in renal cell carcinoma

... First Degree Specialist in Oncology Affiliation:  ... Hospital, Kirenia Camacho, First Degree Specialist in Oncology. Matanzas, Faustino ...

Clinical Trials - CIGB - 19/07/2023 - 1:00pm

CERVICONC-II-300 study

... Oncology Hospital "Marie Curie" ... Idalmis Mesa Vazquez, 1st degree specialist in Oncology. Havana, Gynecobstetric ... Coro", Raysa Ruiz Lorente, 1st Degree Specialist in Oncology. Matanzas, Surgical ...

Clinical Trials - CIGB - 19/07/2023 - 12:53pm

NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.

... First Degree Specialist in Oncology Affiliation:  ... First Degree Specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 19/04/2021 - 3:41pm

Inmunoterapia con la combinación de NGcGM3/VSSP y nimotuzumab en pacientes con cáncer avanzado de pulmón de células no pequeñas (CPCNP)

... NGcGM3. 7. Estado general según el Eastern Cooperative Oncology Group (ECOG) menor igual 2. 8. Pacientes con expectativa de vida de ... 1995;14:350. 9. NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I.2013 www.nccn.org 10. Thongprasert S, Sanguanmitra ...

Ensayos Clínicos - CIM - 21/12/2020 - 11:38am

Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)

... Havana, “National Institute of Oncology and Radiobiology". Yoanna Ivette Flores Vega, MD. First degree specialist in Oncology Research ethics committees:  ...

Clinical Trials - CIM - 21/12/2020 - 11:38am